von Haehling, S., Ebner, N., and Anker, S. D. (2017) Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017. Journal of Cachexia, Sarcopenia and Muscle, 8: 675--680. doi: [10.1002/jcsm.12247](10.1002/jcsm.12247).

The good news first, the *Journal of Cachexia, Sarcopenia and Muscle* (JCSM) has not only maintained its impact factor, but it has even increased it again, now reaching 9.697 as has been published by Thomson Scientific a few weeks ago. To obtain a grip of the impact factor, it has to be acknowledged that it requires calculation of cites to items published in 2014 and 2015 divided by the number of items published in 2014 and 2015. In numbers, we reached a total of 368 cites in 2014 and 272 cites in 2015, summing up to 640 cites in total. This may not seem a lot, but considering that we only published 66 items deemed countable (editorial comments and letters‐to‐the‐editor are not counted), the final impact factor reached 9.697, implying that each of our papers are cited almost 10 times over the course of 2 years. This places JCSM as the number 8 ranked journal among all journals in the category 'Medicine, General and Internal' (Table [1](#jcsm12247-tbl-0001){ref-type="table-wrap"}) and as number 2 ranking publication among all nutrition journals, among which, however, JCSM is still not officially listed by Thomson Scientific (Table [2](#jcsm12247-tbl-0002){ref-type="table-wrap"}).

As we have done before and are not getting tired of, we herewith express our gratitude to all authors, reviewers, and editorial board members for their great efforts to produce JCSM at good quality, and we greatly appreciate and value also the interest and support of all those who enjoy reading JCSM and cite the papers published there. Of course, the Journal would not be what it is without our editorial office team Monika Diek and Corinna Denecke, and we would also like to express our thanks for their professional support!

###### 

Top 10 journals in the field 'medicine: General & Internal'

                                                            **Impact**   **Items**   Issues
  ---- ---------------------------------------------------- ------------ ----------- --------
  1    New England Journal of Medicine                      72.406       670         52
  2    Lancet                                               47.831       646         52
  3    Journal of the American Medical Association (JAMA)   44.405       410         48
  4    British Medical Journal                              20.785       446         52
  5    Annals of Internal Medicine                          17.135       150         24
  6    JAMA Internal Medicine                               16.538       275         12
  7    PLOS Medicine                                        11.862       286         12
  8    Journal of Cachexia, Sarcopenia and Muscle           9.697        88          4
  9    BMC Medicine                                         7.901        418         
  10   Journal of Internal Medicine                         7.598        194         12

###### 

Top 10 journals in the field 'Nutrition & Dietetics', where the Journal of Cachexia, Sarcopenia and Muscle is officially not listed

                                                        **Impact**   **Items**   Issues
  ---- ------------------------------------------------ ------------ ----------- --------
  1    Progress in Lipid Research                       10.583       69          4
  2    Annuals Review of Nutrition                      9.054        44          1
  3    American Journal of Clinical Nutrition           6.926        649         12
  4    Critical Reviews in Food Science and Nutrition   6.077        149         12
  5    International Journal of Obesity                 5.487        502         12
  6    Nutrition Reviews                                5.291        132         12
  7    Advances in Nutrition                            5.233        177         6
  8    Nutrition Research Reviews                       4.844        29          2
  9    Clinical Nutrition                               4.548        375         6
  10   Food Chemistry                                   4.529        3547        24

This year is special to JCSM for several reasons. One is the publication of additional issues this year, the other is the inauguration of our two daughter journals. Indeed, JCSM appears to have sparked more scientific interest in the field of body wasting, cachexia, and sarcopenia, and thus the number of submissions to the main journal remains on the increase. With a 73% rejection rate, we are well aware of the fact that we have to decline publication of many good papers, simply for lack of space. However, we do hope that we are able to give some of these a home in our daughter journals---*JCSM Rapid Communications* and *JCSM Clinical Reports*. The latter is online already since December 2016, and a good number of original research papers has been published since. At the time of writing this editorial in August 2017, the main journal, JCSM, has received already 187 submissions in 2017 alone, proving a steady increase in submissions: last year, this number was 'only' 158. Given these higher numbers of submissions, in 2017 we will move to six issues per year to allow publication of more accepted papers.

We are working hard to provide a timely peer review, which is not always easy, as it is difficult to find appropriate reviewers at times. Articles that are available for the longest time are---not surprisingly---those that have been cited most (Table [3](#jcsm12247-tbl-0003){ref-type="table-wrap"}). Our 'facts and numbers' editorials remain popular (Tables [4](#jcsm12247-tbl-0004){ref-type="table-wrap"} and [5](#jcsm12247-tbl-0005){ref-type="table-wrap"}), and we invite our readers to submit their work or to suggest topics for 'facts and numbers' editorials that are relevant to our readers (Table [6](#jcsm12247-tbl-0006){ref-type="table-wrap"}).

###### 

Top 10 of best cited articles since first publication of the Journal of Cachexia, Sarcopenia and Muscle

       **First Author**   **Title**                                                                                                                                                                                                                   **Type**           **Year**   **Times Cited**   **Reference**
  ---- ------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ---------- ----------------- -------------------------------------------
  1    von Haehling       Cachexia as a major underestimated and unmet medical need: facts and numbers                                                                                                                                                Editorial          2010       203               [1](#jcsm12247-bib-0001){ref-type="ref"}
  2    von Haehling       An overview of sarcopenia: facts and numbers on prevalence and clinical impact                                                                                                                                              Editorial          2010       125               [2](#jcsm12247-bib-0002){ref-type="ref"}
  3    Dalton             The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial   Original article   2011       111               [3](#jcsm12247-bib-0003){ref-type="ref"}
  4    Morley             From Sarcopenia to frailty: a road less travelled                                                                                                                                                                           Editorial          2014       94                [4](#jcsm12247-bib-0004){ref-type="ref"}
  5    Lenk               Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training                                                                                                               Review             2010       90                [5](#jcsm12247-bib-0005){ref-type="ref"}
  6    Fanzani            Molecular and cellular mechanisms of skeletal muscle atrophy: an update                                                                                                                                                     Review             2012       78                [6](#jcsm12247-bib-0006){ref-type="ref"}
  7    Elkina             The role of myostatin in muscle wasting: an overview.                                                                                                                                                                       Review             2011       75                [7](#jcsm12247-bib-0007){ref-type="ref"}
  8    Cesari             Biomarkers of sarcopenia in clinical trials‐recommendations from the International Working Group on Sarcopenia                                                                                                              Original article   2012       72                [8](#jcsm12247-bib-0008){ref-type="ref"}
  9    Mak                Wasting in chronic kidney disease                                                                                                                                                                                           Review             2011       67                [9](#jcsm12247-bib-0009){ref-type="ref"}
  10   von Haehling       From muscle wasting to sarcopenia and myopenia: update 2012                                                                                                                                                                 Editorial          2012       63                [10](#jcsm12247-bib-0010){ref-type="ref"}

###### 

Top 20 of best cited articles published 2014 in the Journal of Cachexia, Sarcopenia and Muscle

       First Author   Title                                                                                                                                                                                                   Type               Times cited   Reference
  ---- -------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ------------- -------------------------------------------
  1    Wakabayashi    Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management                                                                             Review             79            [11](#jcsm12247-bib-0011){ref-type="ref"}
  2    von Haehling   Prevalence, incidence, and clinical impact of cachexia: facts and numbers---update 2014                                                                                                                 Editorial          75            [12](#jcsm12247-bib-0012){ref-type="ref"}
  3    Morley         Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology---update 2014                                                                                                Editorial          69            [13](#jcsm12247-bib-0013){ref-type="ref"}
  4    Morley         From sarcopenia to frailty: a road less travelled                                                                                                                                                       Editorial          59            [4](#jcsm12247-bib-0004){ref-type="ref"}
  5    Ormsbee        Osteosarcopenic obesity: the role of bone, muscle, and fat on health                                                                                                                                    Review             39            [14](#jcsm12247-bib-0014){ref-type="ref"}
  6    Heymsfield     Assessing skeletal muscle mass: historical overview and state of the art                                                                                                                                Review             37            [15](#jcsm12247-bib-0015){ref-type="ref"}
  7    Morley         Are we closer to having drugs to treat muscle wasting disease?                                                                                                                                          Editorial          36            [16](#jcsm12247-bib-0016){ref-type="ref"}
  8    Anker          Muscle wasting disease: a proposal for a new disease classification                                                                                                                                     Editorial          27            [17](#jcsm12247-bib-0017){ref-type="ref"}
  9    Ebner          Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies                                                                                 Meeting Report     26            [18](#jcsm12247-bib-0018){ref-type="ref"}
  10   Pietra         Anamorelin HCl (ONO‐7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia‐cachexia syndrome: preclinical profile                                                                Original Article   26            [19](#jcsm12247-bib-0019){ref-type="ref"}
  11   Fragala        Biomarkers of muscle quality: N‐terminal propeptide of type III procollagen and C‐terminal agrin fragment responses to resistance exercise training in older adults                                     Original Article   25            [20](#jcsm12247-bib-0020){ref-type="ref"}
  12   Palus          Muscle wasting: an overview of recent developments in basic research                                                                                                                                    Review             20            [21](#jcsm12247-bib-0021){ref-type="ref"}
  13   Josiak         Skeletal myopathy in patients with chronic heart failure: significance of anabolic‐androgenic hormones                                                                                                  Review             20            [22](#jcsm12247-bib-0022){ref-type="ref"}
  14   Toledo         Formoterol in the treatment of experimental cancer cachexia: effects on heart function                                                                                                                  Original Article   19            [23](#jcsm12247-bib-0023){ref-type="ref"}
  15   Alchin         Sarcopenia: describing rather than defining a condition                                                                                                                                                 Review             17            [24](#jcsm12247-bib-0024){ref-type="ref"}
  16   Argiles        Cachexia: a problem of energetic inefficiency                                                                                                                                                           Review             16            [25](#jcsm12247-bib-0025){ref-type="ref"}
  17   Rhee           Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?                                                                                                          Editorial          15            [26](#jcsm12247-bib-0026){ref-type="ref"}
  18   Khawaja        Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin‐like growth factor‐1 axis signalling in patients with advanced heart failure   Original Article   15            [27](#jcsm12247-bib-0027){ref-type="ref"}
  19   Mirza          Attenuation of muscle wasting in murine C2C12 myotubes by epigallocatechin‐3‐gallate                                                                                                                    Original Article   15            [28](#jcsm12247-bib-0028){ref-type="ref"}
  20   Kirkman        Anabolic exercise in haemodialysis patients: a randomized controlled pilot study                                                                                                                        Original Article   13            [29](#jcsm12247-bib-0029){ref-type="ref"}

###### 

Top 20 of best cited articles published 2015 in the Journal of Cachexia, Sarcopenia and Muscle

       First Author   Title                                                                                                                                                                                                                                          Type               Times cited   Reference
  ---- -------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ------------- -------------------------------------------
  1    Calvani        Biomarkers for physical frailty and sarcopenia: state of the science and future developments                                                                                                                                                   Review             37            [30](#jcsm12247-bib-0030){ref-type="ref"}
  2    Bowen          Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training                                                                                                                                  Review             36            [31](#jcsm12247-bib-0031){ref-type="ref"}
  3    Ezeoke         Pathophysiology of anorexia in the cancer cachexia syndrome                                                                                                                                                                                    Review             28            [32](#jcsm12247-bib-0032){ref-type="ref"}
  4    Fearon         Request for regulatory guidance for cancer cachexia intervention trials                                                                                                                                                                        Editorial          24            [33](#jcsm12247-bib-0033){ref-type="ref"}
  5    Chen           Ghrelin prevents tumour‐induced and cisplatin‐induced muscle wasting: characterization of multiple mechanisms involved                                                                                                                         Original Article   17            [34](#jcsm12247-bib-0034){ref-type="ref"}
  6    Manger         Skeletal muscle alterations in chronic heart failure: differential effects on quadriceps and diaphragm                                                                                                                                         Original Article   17            [35](#jcsm12247-bib-0035){ref-type="ref"}
  7    Grande         Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review                                                                                                                                        Review             16            [36](#jcsm12247-bib-0036){ref-type="ref"}
  8    Sasso          A framework for prescription in exercise‐oncology research                                                                                                                                                                                     Editorial          14            [37](#jcsm12247-bib-0037){ref-type="ref"}
  9    Cvan Trobec    Influence of cancer cachexia on drug liver metabolism and renal elimination in rats                                                                                                                                                            Original Article   13            [38](#jcsm12247-bib-0038){ref-type="ref"}
  10   Dupuy          Searching for a relevant definition of sarcopenia: results from the cross‐sectional EPIDOS study                                                                                                                                               Original Article   13            [39](#jcsm12247-bib-0039){ref-type="ref"}
  11   Morley         Rapid screening for sarcopenia                                                                                                                                                                                                                 Editorial          12            [40](#jcsm12247-bib-0040){ref-type="ref"}
  12   Stephens       Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients                                                                                                                          Original Article   11            [41](#jcsm12247-bib-0041){ref-type="ref"}
  13   Faber          Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro‐esophageal junction   Original Article   10            [42](#jcsm12247-bib-0042){ref-type="ref"}
  14   Drescher       Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment                                                                                                                                       Review             8             [43](#jcsm12247-bib-0043){ref-type="ref"}
  15   Wakabayashi    Skeletal muscle mass is associated with severe dysphagia in cancer patients                                                                                                                                                                    Original Article   8             [44](#jcsm12247-bib-0044){ref-type="ref"}
  16   Dev            Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic                                                                                                                                                  Original Article   6             [45](#jcsm12247-bib-0045){ref-type="ref"}
  17   Cooper         Understanding and managing cancer‐related weight loss and anorexia: insights from a systematic review of qualitative research                                                                                                                  Review             6             [46](#jcsm12247-bib-0046){ref-type="ref"}
  18   Marino         Activin‐βC modulates cachexia by repressing the ubiquitin‐proteasome and autophagic degradation pathways                                                                                                                                       Original Article   6             [47](#jcsm12247-bib-0047){ref-type="ref"}
  19   Haruta         One‐year intranasal application of growth hormone releasing peptide‐2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient                                                                                   Original Article   5             [48](#jcsm12247-bib-0048){ref-type="ref"}
  20   van Norren     Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric‐restricted ageing mice                                                                                                                           Original Article   5             [49](#jcsm12247-bib-0049){ref-type="ref"}

###### 

Top 20 of best cited articles published 2016 in the Journal of Cachexia, Sarcopenia and Muscle

       First Author    Title                                                                                                                                                                                                      Type               Times cited   Reference
  ---- --------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ------------- -------------------------------------------
  1    Malmstrom       SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes                                                                                                            Original Article   33            [50](#jcsm12247-bib-0050){ref-type="ref"}
  2    Tyrovolas       Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi‐continent study                                                                                  Original Article   12            [51](#jcsm12247-bib-0051){ref-type="ref"}
  3    Sakuma          p62/SQSTM1 but not LC3 is accumulated in sarcopenic muscle of mice                                                                                                                                         Original Article   9             [52](#jcsm12247-bib-0052){ref-type="ref"}
  4    Loncar          Cardiac cachexia: hic et nunc                                                                                                                                                                              Review             8             [53](#jcsm12247-bib-0053){ref-type="ref"}
  5    Go              Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone                                      Original Article   6             [54](#jcsm12247-bib-0054){ref-type="ref"}
  6    de Lima         Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPK signalling in skeletal muscle                                                                              Original Article   6             [55](#jcsm12247-bib-0055){ref-type="ref"}
  7    Lodka           Muscle RING‐fingers 2 and 3 maintain striated‐muscle structure and function                                                                                                                                Original Article   5             [56](#jcsm12247-bib-0056){ref-type="ref"}
  8    Lewis           Increased expression of H19/miR‐675 is associated with a low fat‐free mass index in patients with COPD                                                                                                     Original Article   5             [57](#jcsm12247-bib-0057){ref-type="ref"}
  9    Montano‐Loza    Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis                                                                                                        Original Article   4             [58](#jcsm12247-bib-0058){ref-type="ref"}
  10   Barbosa‐Silva   Prevalence of sarcopenia among community‐dwelling elderly of a medium‐sized South American city: results of the COMO VAI? study                                                                            Original Article   4             [59](#jcsm12247-bib-0059){ref-type="ref"}
  11   Penna           Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting                                                                                                                    Original Article   4             [60](#jcsm12247-bib-0060){ref-type="ref"}
  12   Vries           Patient‐centred physical therapy is (cost‐) effective in increasing physical activity and reducing frailty in older adults with mobility problems: a randomized controlled trial with 6 months follow‐up   Original Article   4             [61](#jcsm12247-bib-0061){ref-type="ref"}
  13   Batista         Cachexia‐associated adipose tissue morphological rearrangement in gastrointestinal cancer patients                                                                                                         Original Article   3             [62](#jcsm12247-bib-0062){ref-type="ref"}
  14   Giron           Conversion of leucine to β‐hydroxy‐β‐methylbutyrate by α‐keto isocaproate dioxygenase is required for a potent stimulation of protein synthesis in L6 rat myotubes                                         Original Article   3             [63](#jcsm12247-bib-0063){ref-type="ref"}
  15   Lainscak        ACT‐ONE‐ACTION at last on cancer cachexia by adapting a novel action beta‐blocker                                                                                                                          Editorial          3             [64](#jcsm12247-bib-0064){ref-type="ref"}
  16   Berger          Dysfunction of respiratory muscles in critically ill patients on the intensive care unit                                                                                                                   Review             3             [65](#jcsm12247-bib-0065){ref-type="ref"}
  17   Musolino        Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation                                                                                  Original Article   3             [66](#jcsm12247-bib-0066){ref-type="ref"}
  18   Neves           White adipose tissue cells and the progression of cachexia: inflammatory pathways                                                                                                                          Original Article   2             [67](#jcsm12247-bib-0067){ref-type="ref"}
  19   Polge           UBE2B is implicated in myofibrillar protein loss in catabolic C2C12 myotubes                                                                                                                               Original Article   2             [68](#jcsm12247-bib-0068){ref-type="ref"}
  20   Pinto           Impact of creatine supplementation in combination with resistance training on lean mass in the elderly                                                                                                     Original Article   2             [69](#jcsm12247-bib-0069){ref-type="ref"}

Finally, we would like to draw attention to the upcoming Cachexia Conference to be held between December 8--10, 2017 in Rome, Italy. The conference became an annual meeting already 2 years ago, and it is a source of stimulating ideas and exchange between clinicians and researchers in the field of cachexia and wasting. Data on the final program and more information is to be found at [http://society‐scwd.org](http://society-scwd.org).

The authors certify that they comply with the ethical guidelines for authorship and publishing of the *Journal of Cachexia, Sarcopenia and Muscle*. [71](#jcsm12247-bib-0071){ref-type="ref"}
